Precision cardiovascular medicine in China.

Abstract

In mainland China, hospitalization expenses for patients with cardiovascular and cerebrovascular diseases have rapidly increased since 2004 and currently exceed the growth rate of the national gross domestic product.[1] One reason for these high expenses is that the traditional one-size-for-all medical model results in low treatment efficacy. Precision and individualized medical models may help reduce the medical burden and provide a sustainable medical model.